We pursue a sustainable growth model by integrating social and environmental aspects into our corporate strategy, mindful that there can be no long-term economic development without responsible action.
We pursue a sustainable growth model by integrating social and environmental aspects into our corporate strategy, mindful that there can be no long-term economic development without responsible action.
We have a long history of entrepreneurial passion and a strong reputation and a desire to continue growing and creating value in an ethical, enduring, and sustainable way, all while respecting the laws and regulations that apply in the countries where we operate, protecting people and the environment, and supplying safe, high-quality products.
For more information, please refer to the Consolidated Sustainability Statement (included in the Integrated Consolidated Financial Statements 2024)
Continued to purchase 100% renewable energy, in countries where this is possible*
In 2024, installation of solar panels was completed in Türkiye, reaching installed power of approximately 860 kWp, in addition to systems already installed in 2022 in Ireland and Spain. By 2026, the Group aims to install further new systems at plants in Italy (Campoverde) and Tunisia, as well as expanding the system in Spain, reaching installed power of 11,000 kWp
Approximately € 2.7 million in donations to the community**
Around 1,600 patients affected by rare diseases supported through the Patient Assistance Programme, the Co-Pay Assistance Programme and similar programmes
Revenue
Formalised D&I strategy and policy. A global network of more than 60 D&I Champions was launched
Formalised Environment, Health and Safety Policy, and Human Rights Policy
Defined a roadmap to obtain ISO certifications for various Group plants
Reduce Scopes 1 and 2 CO2eq emissions by 20% by 2030, using 2022 as a baseline
59 ESG Audits: 44 new suppliers audited in 2024 (via desk audits) on ESG topics, and 15 follow-ups performed by an independent third party
Around 180 supplier audits conducted by the pharmaceutical and chemical-pharmaceutical division, mainly on product quality and safety
*This figure excludes Tunisia, where renewable energy is not available. Please refer to the 2024 Sustainability Statement for further details.
**In the form of both monetary and product donations (measured at market value).